• home
  • about us
  • contact us
Browse by Issue
Products
Enterisol® Ileitis
Enterisol® SC-54
Ingelvac® ERY-ALC
Ingelvac® HP-1/HPE-1
Ingelvac® M. hyo
Ingelvac® PRRS ATP
Ingelvac® PRRS MLV
Reprocyc PRRS/PLE
Diseases
Atinobacillus Pleuropneumoniae
B. hydysenteriae
E. Coli
Erysipelas
Erysipelothrix rhusiopathiae
Haemophilus parasuis
Ileitis
Leptospira
Mycoplasma hyponeumoniae (M. hyo)
Parvo Virus
PCVAD
PCV2
PMWS
PRRS
PRV
Salmonella choleraesuis
Salmonellosis
SIV
Worms

Print This Article

Pinpoint ileitis control efforts for less waste

To a hammer, the old saying goes, everything looks like a nail. Such was ileitis management with the blunt instrument of continuous antibiotic medication. Now, studies are suggesting that under today's improved health management on intensive operations, continuously feeding medications without a diagnosis of a susceptible bacterial infection may be a losing proposition.

Improved ileitis diagnostic tools now permit accurate diagnosis on live animals via blood or feces, permitting producers to pinpoint the optimal time to apply ileitis prevention/control intervention strategies. Blood tests can demonstrate exposure starting two to three weeks after infection. Polymerase Chain Reaction tests find the bacterial DNA in feces. Plus, several post-mortem tests remain useful as tools to confirm suspicion of ileitis based on clinical signs.

If, for any reason, vaccination 3-4 weeks before Lawsonia exposure is not possible, targeted feed medication after expected exposure, but before a clinical outbreak, is another option. This measure inhibits ileitis while allowing immunity to develop. The short medication period required with Denagard® 10 — as little as 10 days — accommodates such short-term strategic use while reducing cost compared to other medications. To ensure uniform, consistent long-term population immunity, the short phase feed medication period can be preceded by vaccination against ileitis.

Dritz S.; et. al. 2002. Effects of administration of antimicrobials in feed on growth rate and feed efficiency of pigs in multisite production systems. J Am Vet Med Assoc 220(11):1690-1695.

Collins A.; et. al. 2001. Immunity to Lawsonia intracellularis. Proc Leman Swine Conf 2001: 115-120.

From BIVI

Get further technical information

Boehringer Ingelheim Vetmedica gives you access to several additional learning tools to ease your transition into vaccine-based ileitis management, including a new step-by-step drinking water vaccination training video on CD, moderated by swine practitioner Dr. Steve Henry. A vaccination checklist, guidelines for best application and a product information sheet are also available. Request free copies by e-mailing tritter@bi-vetmedica.com

Ileitis decision-making flow chart

Step I
Consider: Is ileitis present?

Consider one or more signs of possible ileitis exposure in the herd:

  • Sub-optimum growth
  • Sudden deaths at first market sort, possibly including bloody diarrhea
  • Wide weight distributions
  • Diarrhea

Step II
Confirm Lawsonia/pinpoint exposure timing

Use diagnostic tools to confirm that Lawsonia is present in the herd and to isolate the point in production at which animals are being exposed and infected:

  • Live-animal blood tests can identify antibodies to Lawsonia, which indicates infection has occurred.

  • The most cost-effective herd-level testing is done by “cross-sectional serological profiling:” testing a random sample of animals in several different age groups.

Step III

Is it possible to vaccinate 3-4 weeks prior to exposure?

Step IV

Limited judicious use of water or injectable antibiotics under veterinary supervision can be reserved to treat acute outbreaks that escape the planned control program.

Back to Top